Skip to content

Research & Literature

Last updated:

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature

Visualize citation networks across 112 referenced papers

Top Authors

Top Institutions

References

  1. 1

    The case for vaccine development in the strategy to eradicate river blindness (onchocerciasis) from Africa.

    Makepeace BL, Babayan SA, Lustigman S, Taylor DW

    Expert review of vaccines 2015; (14(9)):1163-5 doi:10.1586/14760584.2015.1059281.

    PMID: 26091691
  2. 2

    Risk Factors for Chronic Intertrigo of the Lymphedema Leg in Southern India: A Case-Control Study.

    De Britto LJ, Yuvaraj J, Kamaraj P, et al.

    The international journal of lower extremity wounds 2015; (14(4)):377-83 doi:10.1177/1534734615604289.

    PMID: 26353823
  3. 3

    [Risk factors associated with leg erysipelas (cellulitis) in sub-Saharan Africa: A multicentre case-control study].

    Pitché P, Diatta B, Faye O, et al.

    Annales de dermatologie et de venereologie 2015; (142(11)):633-8.

    PMID: 26364000
  4. 4

    The Effect of Hygiene-Based Lymphedema Management in Lymphatic Filariasis-Endemic Areas: A Systematic Review and Meta-analysis.

    Stocks ME, Freeman MC, Addiss DG

    PLoS neglected tropical diseases 2015; (9(10)):e0004171 doi:10.1371/journal.pntd.0004171.

    PMID: 26496129
  5. 5

    Absence of the Filarial Endosymbiont Wolbachia in Seal Heartworm (Acanthocheilonema spirocauda) but Evidence of Ancient Lateral Gene Transfer.

    Keroack CD, Wurster JI, Decker CG, et al.

    The Journal of parasitology 2016; (102(3)):312-8 doi:10.1645/15-872.

    PMID: 26859724
  6. 6

    THE ARTHROPOD-BORNE ONCHOCERCIASIS: IS IT DESERVED TO BE NEGLECTED?.

    El-Bahnasawy MM, Morsy AT, Morsy TA

    Journal of the Egyptian Society of Parasitology 2015; (45(3)):639-54 doi:10.12816/0017932.

    PMID: 26939243
  7. 7

    "Filarial dance sign" real-time ultrasound diagnosis of filarial oophoritis.

    Panditi S, Shelke AG, Thummalakunta LN

    Journal of clinical ultrasound : JCU 2016; (44(8)):500-1 doi:10.1002/jcu.22359.

    PMID: 27130361
  8. 8

    Microfilariae, a Common Parasite in an Unusual Site: A Case Report with Literature Review.

    Dhanya CS, Jayaprakash HT

    Journal of clinical and diagnostic research : JCDR 2016; (10(4)):ED08-9 doi:10.7860/JCDR/2016/16042.7563.

    PMID: 27190816
  9. 9

    Mansonella ozzardi: a neglected New World filarial nematode.

    Lima NF, Veggiani Aybar CA, Dantur Juri MJ, Ferreira MU

    Pathogens and global health 2016; (110(3)):97-107 doi:10.1080/20477724.2016.1190544.

    PMID: 27376501
  10. 10

    Economic Costs and Benefits of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India.

    Stillwaggon E, Sawers L, Rout J, et al.

    The American journal of tropical medicine and hygiene 2016; (95(4)):877-884 doi:10.4269/ajtmh.16-0286.

    PMID: 27573626
  11. 11

    Determinants of parasite drug resistance in human lymphatic filariasis.

    Cobo F

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 2016; (29(6)):288-295.

    PMID: 27858056
  12. 12

    Filariasis in Mandible and Maxilla: A Rare Entity-First Report of a Case.

    Lenka S, Panda NK, Mishra S, Rathor K

    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 2017; (75(4)):769.e1-769.e4 doi:10.1016/j.joms.2016.10.028.

    PMID: 27875706
  13. 13

    Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.

    Aljayyoussi G, Tyrer HE, Ford L, et al.

    Scientific reports 2017; (7(1)):210 doi:10.1038/s41598-017-00322-5.

    PMID: 28303006
  14. 14

    Pre-control relationship of onchocercal skin disease with onchocercal infection in Guinea Savanna, Northern Nigeria.

    Murdoch ME, Murdoch IE, Evans J, et al.

    PLoS neglected tropical diseases 2017; (11(3)):e0005489 doi:10.1371/journal.pntd.0005489.

    PMID: 28355223
  15. 15

    Defining Brugia malayi and Wolbachia symbiosis by stage-specific dual RNA-seq.

    Grote A, Voronin D, Ding T, et al.

    PLoS neglected tropical diseases 2017; (11(3)):e0005357 doi:10.1371/journal.pntd.0005357.

    PMID: 28358880
  16. 16

    Migratory phase of Litomosoides sigmodontis filarial infective larvae is associated with pathology and transient increase of S100A9 expressing neutrophils in the lung.

    Karadjian G, Fercoq F, Pionnier N, et al.

    PLoS neglected tropical diseases 2017; (11(5)):e0005596 doi:10.1371/journal.pntd.0005596.

    PMID: 28486498
  17. 17

    The Population Biology and Transmission Dynamics of Loa loa.

    Whittaker C, Walker M, Pion SDS, et al.

    Trends in parasitology 2018; (34(4)):335-350 doi:10.1016/j.pt.2017.12.003.

    PMID: 29331268
  18. 18

    Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.

    Cano J, Basáñez MG, O'Hanlon SJ, et al.

    Parasites & vectors 2018; (11(1)):70 doi:10.1186/s13071-018-2655-5.

    PMID: 29382363
  19. 19

    Operationalization of the test and not treat strategy to accelerate the elimination of onchocerciasis and lymphatic filariasis in Central Africa.

    Kamgno J, Nana-Djeunga HC, Pion SD, et al.

    International health 2018; (10(suppl_1)):i49-i53 doi:10.1093/inthealth/ihx051.

    PMID: 29471340
  20. 20

    Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.

    Komlan K, Vossberg PS, Gantin RG, et al.

    PLoS neglected tropical diseases 2018; (12(3)):e0006312 doi:10.1371/journal.pntd.0006312.

    PMID: 29494606
  21. 21

    Brugia malayi infection in ferrets - A small mammal model of lymphatic filariasis.

    Jackson-Thompson BM, Kim SY, Jaiswal S, et al.

    PLoS neglected tropical diseases 2018; (12(3)):e0006334 doi:10.1371/journal.pntd.0006334.

    PMID: 29601572
  22. 22

    Case Report: Probable Case of Spontaneous Encephalopathy Due to Loiasis and Dramatic Reduction of Loa loa Microfilariaemia with Prolonged Repeated Courses of Albendazole.

    Arrey-Agbor DB, Nana-Djeunga HC, Mogoung-Wafo AE, et al.

    The American journal of tropical medicine and hygiene 2018; (99(1)):112-115 doi:10.4269/ajtmh.17-0664.

    PMID: 29741149
  23. 23

    Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature.

    Budge PJ, Herbert C, Andersen BJ, Weil GJ

    PLoS neglected tropical diseases 2018; (12(5)):e0006454 doi:10.1371/journal.pntd.0006454.

    PMID: 29768412
  24. 24

    Mansonellosis: current perspectives.

    Ta-Tang TH, Crainey JL, Post RJ, et al.

    Research and reports in tropical medicine 2018; (9()):9-24 doi:10.2147/RRTM.S125750.

    PMID: 30050351
  25. 25

    An overview of lymphatic filariasis lymphedema.

    Rajasekaram S, Anuradha R, Manokaran G, Bethunaickan R

    Lymphology 2017; (50(4)):164-182.

    PMID: 30248721
  26. 26

    Primary retroperitoneal filariasis: a common disease of tropics with uncommon presentation and review of literature.

    Diwakar DK, Wadhwani N, Prasad N, Gupta A

    BMJ case reports 2018; (2018()) doi:10.1136/bcr-2018-226217.

    PMID: 30257872
  27. 27

    A surveillance system for lymphatic filariasis after its elimination in Sri Lanka.

    Rahman MA, Yahathugoda TC, Tojo B, et al.

    Parasitology international 2019; (68(1)):73-78 doi:10.1016/j.parint.2018.10.003.

    PMID: 30308253
  28. 28

    Prevalence and intensity of Loa loa infection over twenty-three years in three communities of the Mbalmayo health district (Central Cameroon).

    Mogoung-Wafo AE, Nana-Djeunga HC, Domche A, et al.

    BMC infectious diseases 2019; (19(1)):146 doi:10.1186/s12879-019-3776-y.

    PMID: 30760228
  29. 29

    Importance of ivermectin to human onchocerciasis: past, present, and the future.

    Cupp EW, Mackenzie CD, Unnasch TR

    Research and reports in tropical medicine 2011; (2()):81-92 doi:10.2147/RRTM.S19477.

    PMID: 30881181
  30. 30

    A detailed review of the mosquitoes (Diptera: Culicidae) of Iran and their medical and veterinary importance.

    Azari-Hamidian S, Norouzi B, Harbach RE

    Acta tropica 2019; (194()):106-122 doi:10.1016/j.actatropica.2019.03.019.

    PMID: 30898616
  31. 31

    Human Migration and the Spread of the Nematode Parasite Wuchereria bancrofti.

    Small ST, Labbé F, Coulibaly YI, et al.

    Molecular biology and evolution 2019; (36(9)):1931-1941 doi:10.1093/molbev/msz116.

    PMID: 31077328
  32. 32

    Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.

    Edi C, Bjerum CM, Ouattara AF, et al.

    PLoS neglected tropical diseases 2019; (13(5)):e0007325 doi:10.1371/journal.pntd.0007325.

    PMID: 31107869
  33. 33

    Influence of seasonal variation on reported filarial attacks among people living with lymphedema in Ghana.

    Kwarteng A, Arthur YD, Yamba JK, et al.

    BMC infectious diseases 2019; (19(1)):442 doi:10.1186/s12879-019-4084-2.

    PMID: 31109288
  34. 34

    The Efficacy of Doxycycline Treatment on Mansonella perstans Infection: An Open-Label, Randomized Trial in Ghana.

    Batsa Debrah L, Phillips RO, Pfarr K, et al.

    The American journal of tropical medicine and hygiene 2019; (101(1)):84-92 doi:10.4269/ajtmh.18-0491.

    PMID: 31162017
  35. 35

    Projected Number of People With Onchocerciasis-Loiasis Coinfection in Africa, 1995 to 2025.

    Vinkeles Melchers NVS, Coffeng LE, Boussinesq M, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020; (70(11)):2281-2289 doi:10.1093/cid/ciz647.

    PMID: 31304961
  36. 36

    Optimization and evaluation of the Esperanza Window Trap to reduce biting rates of Simulium damnosum sensu lato in Northern Uganda.

    Loum D, Cozart D, Lakwo T, et al.

    PLoS neglected tropical diseases 2019; (13(7)):e0007558 doi:10.1371/journal.pntd.0007558.

    PMID: 31310607
  37. 37

    Review of Dancing Parasites in Lymphatic Filariasis.

    Dietrich CF, Chaubal N, Hoerauf A, et al.

    Ultrasound international open 2019; (5(2)):E65-E74 doi:10.1055/a-0918-3678.

    PMID: 31312785
  38. 38

    Anti-Wolbachia therapy for onchocerciasis & lymphatic filariasis: Current perspectives.

    Wan Sulaiman WA, Kamtchum-Tatuene J, Mohamed MH, et al.

    The Indian journal of medical research 2019; (149(6)):706-714 doi:10.4103/ijmr.IJMR_454_17.

    PMID: 31496523
  39. 39

    Systems analysis-based assessment of post-treatment adverse events in lymphatic filariasis.

    Andersen BJ, Rosa BA, Kupritz J, et al.

    PLoS neglected tropical diseases 2019; (13(9)):e0007697 doi:10.1371/journal.pntd.0007697.

    PMID: 31557154
  40. 40

    Pyruvate produced by Brugia spp. via glycolysis is essential for maintaining the mutualistic association between the parasite and its endosymbiont, Wolbachia.

    Voronin D, Schnall E, Grote A, et al.

    PLoS pathogens 2019; (15(9)):e1008085 doi:10.1371/journal.ppat.1008085.

    PMID: 31568486
  41. 41

    Supervision and support in surgical practice using mobile platform: a case of mass hydrocele surgeries in remote regions.

    Akoko L, Mwanga A, Chikawe M, et al.

    mHealth 2019; (5()):41 doi:10.21037/mhealth.2019.09.05.

    PMID: 31620468
  42. 42

    Cost-effectiveness and social outcomes of a community-based treatment for podoconiosis lymphoedema in the East Gojjam zone, Ethiopia.

    Hounsome N, Kassahun MM, Ngari M, et al.

    PLoS neglected tropical diseases 2019; (13(10)):e0007780 doi:10.1371/journal.pntd.0007780.

    PMID: 31644556
  43. 43

    Encephalopathy in a patient with loiasis treated with albendazole: A case report.

    Volpicelli L, De Angelis M, Morano A, et al.

    Parasitology international 2020; (75()):102006 doi:10.1016/j.parint.2019.102006.

    PMID: 31676328
  44. 44

    Atypical Clinical Manifestations of Loiasis and Their Relevance for Endemic Populations.

    Buell KG, Whittaker C, Chesnais CB, et al.

    Open forum infectious diseases 2019; (6(11)):ofz417 doi:10.1093/ofid/ofz417.

    PMID: 31696139
  45. 45

    Imported loiasis in France: a retrospective analysis of 167 cases with comparison between sub-Saharan and non sub-Saharan African patients.

    Bouchaud O, Matheron S, Loarec A, et al.

    BMC infectious diseases 2020; (20(1)):63 doi:10.1186/s12879-019-4740-6.

    PMID: 31959110
  46. 46

    Macrofilaricides: An Unmet Medical Need for Filarial Diseases.

    Hawryluk NA

    ACS infectious diseases 2020; (6(4)):662-671 doi:10.1021/acsinfecdis.9b00469.

    PMID: 32091199
  47. 47

    Economic benefits and costs of surgery for filarial hydrocele in Malawi.

    Sawers L, Stillwaggon E, Chiphwanya J, et al.

    PLoS neglected tropical diseases 2020; (14(3)):e0008003 doi:10.1371/journal.pntd.0008003.

    PMID: 32210436
  48. 48

    Low transmission of Wuchereria bancrofti in cross-border districts of Côte d'Ivoire: A great step towards lymphatic filariasis elimination in West Africa.

    Yokoly FN, Zahouli JBZ, Méite A, et al.

    PloS one 2020; (15(4)):e0231541 doi:10.1371/journal.pone.0231541.

    PMID: 32282840
  49. 49

    Nearly Complete Genome Sequence of Brugia malayi Strain FR3.

    Tracey A, Foster JM, Paulini M, et al.

    Microbiology resource announcements 2020; (9(24)) doi:10.1128/MRA.00154-20.

    PMID: 32527783
  50. 50

    Burden of disease in Gabon caused by loiasis: a cross-sectional survey.

    Veletzky L, Hergeth J, Stelzl DR, et al.

    The Lancet. Infectious diseases 2020; (20(11)):1339-1346 doi:10.1016/S1473-3099(20)30256-5.

    PMID: 32585133
  51. 51

    Economic Costs and Benefits of Community-Based Lymphedema-Management Programs for Lymphatic Filariasis in India.

    Sawers L, Stillwaggon E

    The American journal of tropical medicine and hygiene 2020; (103(1)):295-302.

    PMID: 32653050
  52. 52

    Onchocerciasis (river blindness) - more than a century of research and control.

    Brattig NW, Cheke RA, Garms R

    Acta tropica 2021; (218()):105677 doi:10.1016/j.actatropica.2020.105677.

    PMID: 32857984
  53. 53

    EnDPoINT: protocol for an implementation research study to integrate a holistic package of physical health, mental health and psychosocial care for podoconiosis, lymphatic filariasis and leprosy into routine health services in Ethiopia.

    Semrau M, Ali O, Deribe K, et al.

    BMJ open 2020; (10(10)):e037675 doi:10.1136/bmjopen-2020-037675.

    PMID: 33060082
  54. 54

    Molecular Epidemiology of Mansonella Species in Gabon.

    Sandri TL, Kreidenweiss A, Cavallo S, et al.

    The Journal of infectious diseases 2021; (223(2)):287-296 doi:10.1093/infdis/jiaa670.

    PMID: 33099649
  55. 55

    Corallopyronin A for short-course anti-wolbachial, macrofilaricidal treatment of filarial infections.

    Schiefer A, Hübner MP, Krome A, et al.

    PLoS neglected tropical diseases 2020; (14(12)):e0008930 doi:10.1371/journal.pntd.0008930.

    PMID: 33284808
  56. 56

    Individual risk of post-ivermectin serious adverse events in subjects infected with Loa loa.

    Chesnais CB, Pion SD, Boullé C, et al.

    EClinicalMedicine 2020; (28()):100582 doi:10.1016/j.eclinm.2020.100582.

    PMID: 33294807
  57. 57

    Dual RNAseq analyses at soma and germline levels reveal evolutionary innovations in the elephantiasis-agent Brugia malayi, and adaptation of its Wolbachia endosymbionts.

    Chevignon G, Foray V, Pérez-Jiménez MM, et al.

    PLoS neglected tropical diseases 2021; (15(1)):e0008935 doi:10.1371/journal.pntd.0008935.

    PMID: 33406151
  58. 58

    Preliminary comparison between an in-house real-time PCR vs microscopy for the diagnosis of Loa loa and Mansonella perstans.

    Formenti F, Tang TT, Tamarozzi F, et al.

    Acta tropica 2021; (216()):105838 doi:10.1016/j.actatropica.2021.105838.

    PMID: 33484727
  59. 59

    Human filariasis-contributions of the Litomosoides sigmodontis and Acanthocheilonema viteae animal model.

    Risch F, Ritter M, Hoerauf A, Hübner MP

    Parasitology research 2021; (120(12)):4125-4143 doi:10.1007/s00436-020-07026-2.

    PMID: 33547508
  60. 60

    An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.

    Jambulingam P, Kuttiatt VS, Krishnamoorthy K, et al.

    PLoS neglected tropical diseases 2021; (15(2)):e0009069 doi:10.1371/journal.pntd.0009069.

    PMID: 33591979
  61. 61

    Health beliefs and health seeking behavior towards lymphatic filariasis morbidity management and disability prevention services in Luangwa District, Zambia: Community and provider perspectives.

    Maritim P, Silumbwe A, Zulu JM, et al.

    PLoS neglected tropical diseases 2021; (15(2)):e0009075 doi:10.1371/journal.pntd.0009075.

    PMID: 33617551
  62. 62

    An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.

    Supali T, Djuardi Y, Christian M, et al.

    PLoS neglected tropical diseases 2021; (15(3)):e0009294 doi:10.1371/journal.pntd.0009294.

    PMID: 33780481
  63. 63

    Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study.

    Khaemba C, Barry A, Omondi WP, et al.

    Pharmaceuticals (Basel, Switzerland) 2021; (14(3)) doi:10.3390/ph14030264.

    PMID: 33804133
  64. 64

    Unusual Localization of Blood-Borne Loa loa Microfilariae in the Skin Depends on Microfilarial Density in the Blood: Implications for Onchocerciasis Diagnosis in Coendemic Areas.

    Niamsi-Emalio Y, Nana-Djeunga HC, Chesnais CB, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021; (72(Suppl 3)):S158-S164 doi:10.1093/cid/ciab255.

    PMID: 33909066
  65. 65

    An Overview of the Management of Mansonellosis.

    Ta-Tang TH, Luz SLB, Crainey JL, Rubio JM

    Research and reports in tropical medicine 2021; (12()):93-105 doi:10.2147/RRTM.S274684.

    PMID: 34079424
  66. 66

    A rare clinical presentation of human Dirofilaria repens infection as a pseudo-tumour of the epididymis - Case Report.

    Nagy V, Nagyová D

    Annals of agricultural and environmental medicine : AAEM 2021; (28(2)):348-351 doi:10.26444/aaem/136387.

    PMID: 34184522
  67. 67

    Comparison of Immunochromatographic Test (ICT) and Filariasis Test Strip (FTS) for Detecting Lymphatic Filariasis Antigen in American Samoa, 2016.

    Sheel M, Lau CL, Sheridan S, et al.

    Tropical medicine and infectious disease 2021; (6(3)) doi:10.3390/tropicalmed6030132.

    PMID: 34287387
  68. 68

    Human Filariasis in Travelers and Migrants: A Retrospective 25-year Analysis at the Institute of Tropical Medicine, Antwerp, Belgium.

    Bottieau E, Huits R, Van Den Broucke S, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022; (74(11)):1972-1978 doi:10.1093/cid/ciab751.

    PMID: 34463732
  69. 69

    Disease Burden Estimation of Lymphatic Filariasis in an Endemic Area.

    Nagavarapu S, Singh R, Vaish S, Gogia SB

    Lymphatic research and biology 2022; (20(3)):319-324 doi:10.1089/lrb.2020.0014.

    PMID: 34619046
  70. 70

    The implementation and impact of a pilot hydrocele surgery camp for LF-endemic communities in Ethiopia.

    Beyene AD, Kebede F, Mammo BM, et al.

    PLoS neglected tropical diseases 2021; (15(10)):e0009403 doi:10.1371/journal.pntd.0009403.

    PMID: 34695118
  71. 71

    Unlocking Trust in Community Health Systems: Lessons From the Lymphatic Filariasis Morbidity Management and Disability Prevention Pilot Project in Luangwa District, Zambia.

    Zulu JM, Maritim P, Silumbwe A, et al.

    International journal of health policy and management 2022; (11(1)):80-89 doi:10.34172/ijhpm.2021.133.

    PMID: 34814671
  72. 72

    Assessment of the Impact of Morbidity Management and Disability Prevention for Lymphatic Filariasis on the Disease Burden in Villupuram District of Tamil Nadu, India.

    Mathiarasan L, Das LK, Krishnakumari A

    Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine 2021; (46(4)):657-661 doi:10.4103/ijcm.IJCM_12_21.

    PMID: 35068729
  73. 73

    Development and Introduction of the Filariasis Test Strip: A New Diagnostic Test for the Global Program to Eliminate Lymphatic Filariasis.

    Pantelias A, King JD, Lammie P, Weil GJ

    The American journal of tropical medicine and hygiene 2022; (106(5_Suppl)):56-60 doi:10.4269/ajtmh.21-0990.

    PMID: 35292584
  74. 74

    Current perspective of new anti-Wolbachial and direct-acting macrofilaricidal drugs as treatment strategies for human filariasis.

    Ehrens A, Hoerauf A, Hübner MP

    GMS infectious diseases 2022; (10()):Doc02 doi:10.3205/id000079.

    PMID: 35463816
  75. 75

    A call for loiasis to be added to the WHO list of neglected tropical diseases.

    Jacobsen KH, Andress BC, Bhagwat EA, et al.

    The Lancet. Infectious diseases 2022; (22(10)):e299-e302 doi:10.1016/S1473-3099(22)00064-0.

    PMID: 35500592
  76. 76

    Characterization of a novel microfilarial antigen for diagnosis of Wuchereria bancrofti infections.

    Greene SE, Fischer K, Choi YJ, et al.

    PLoS neglected tropical diseases 2022; (16(5)):e0010407 doi:10.1371/journal.pntd.0010407.

    PMID: 35604906
  77. 77

    [Elephantiasis of the lower limb: Treatment of seven cases using the modified Charles technique].

    Asséré YAGRA, Kaba L, Assi-Dje Bi Dje V, Akpro LR

    Annales de chirurgie plastique et esthetique 2023; (68(4)):354-360 doi:10.1016/j.anplas.2022.06.010.

    PMID: 35927107
  78. 78

    Diethylcarbamazine citrate-fortified salt for lymphatic filariasis elimination in India.

    Sabesan S, Krishnamoorthy K, Hoti SL, et al.

    The Indian journal of medical research 2022; (155(3&4)):347-355 doi:10.4103/ijmr.ijmr_171_22.

    PMID: 36124509
  79. 79

    Filariasis diagnosed by real-time ultrasound scanning as filarial dance sign - A case report.

    Gurung S, Karki S, Kharal K, et al.

    IDCases 2022; (30()):e01621 doi:10.1016/j.idcr.2022.e01621.

    PMID: 36210858
  80. 80

    Application of loop mediated isothermal amplification (LAMP) assays for the detection of Onchocerca volvulus, Loa loa and Mansonella perstans in humans and vectors.

    Amambo GN, Innocentia N, Abong RA, et al.

    Frontiers in tropical diseases 2023; (3()):1016176 doi:10.3389/fitd.2022.1016176.

    PMID: 36684508
  81. 81

    Wolbachia Ferrochelatase as a potential drug target against filarial infections.

    Biney C, Graham GE, Asiedu E, et al.

    Journal of molecular graphics & modelling 2023; (122()):108490 doi:10.1016/j.jmgm.2023.108490.

    PMID: 37121168
  82. 82

    Onchocercoma of the scalp: A case report.

    Savadogo I, Ido FAHA, Ouedraogo AS, Ouattara S

    IDCases 2023; (33()):e01811 doi:10.1016/j.idcr.2023.e01811.

    PMID: 37273776
  83. 83

    The search for better treatment strategies for mansonellosis: an expert perspective.

    Ferreira MU, Crainey JL, Gobbi FG

    Expert opinion on pharmacotherapy 2023; (24(15)):1685-1692 doi:10.1080/14656566.2023.2240235.

    PMID: 37477269
  84. 84

    Real time ultrasound diagnosis of ovarian and pelvic filariasis by filarial dance sign.

    Bayaskar M, Bhende V

    Journal of radiology case reports 2023; (17(7)):1-7 doi:10.3941/jrcr.v17i7.4675.

    PMID: 37602196
  85. 85

    Diethylcarbamazine elicits Ca2+ signals through TRP-2 channels that are potentiated by emodepside in Brugia malayi muscles.

    Williams PDE, Kashyap SS, Robertson AP, Martin RJ

    Antimicrobial agents and chemotherapy 2023; (67(10)):e0041923 doi:10.1128/aac.00419-23.

    PMID: 37728916
  86. 86

    The African eye worm: current understanding of the epidemiology, clinical disease, and treatment of loiasis.

    Ramharter M, Butler J, Mombo-Ngoma G, et al.

    The Lancet. Infectious diseases 2024; (24(3)):e165-e178 doi:10.1016/S1473-3099(23)00438-3.

    PMID: 37858326
  87. 87

    Implementation and Outcomes of a Pilot Collaborative Surgical Hydrocele Training in Côte d'Ivoire.

    Montes K, Angoa G, Bjerum CM, et al.

    The American journal of tropical medicine and hygiene 2024; (110(1)):194-198 doi:10.4269/ajtmh.23-0554.

    PMID: 37956446
  88. 88

    Presumed Onchocerciasis Chorioretinitis Spilling over into North America, Europe and Middle East.

    Mansour A, Rodriguez L, Mansour H, et al.

    Diagnostics (Basel, Switzerland) 2023; (13(24)) doi:10.3390/diagnostics13243626.

    PMID: 38132210
  89. 89

    Filarial disease in the Brazilian Amazon and emerging opportunities for treatment and control.

    Portela CS, Mendes de Araújo CP, Moura Sousa P, et al.

    Current research in parasitology & vector-borne diseases 2024; (5()):100168 doi:10.1016/j.crpvbd.2023.100168.

    PMID: 38283060
  90. 90

    Elimination of lymphatic filariasis as a public health problem in Malawi.

    Chiphwanya J, Mkwanda S, Kabuluzi S, et al.

    PLoS neglected tropical diseases 2024; (18(2)):e0011957 doi:10.1371/journal.pntd.0011957.

    PMID: 38363794
  91. 91

    Repurposed Drugs That Activate Autophagy in Filarial Worms Act as Effective Macrofilaricides.

    Voronin D, Tricoche N, Peguero R, et al.

    Pharmaceutics 2024; (16(2)) doi:10.3390/pharmaceutics16020256.

    PMID: 38399310
  92. 92

    Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia.

    Kanza EM, Nyathirombo A, Larbelee JP, et al.

    Parasites & vectors 2024; (17(1)):137 doi:10.1186/s13071-023-06087-3.

    PMID: 38491528
  93. 93

    Lessons from integrating mental health as part of lymphatic filariasis morbidity management and disability prevention services in Jigawa State, Nigeria.

    Amanyi-Enegela JA, Badaki JA, Pali M, et al.

    International health 2024; (16(16 Suppl 1)):i22-i29 doi:10.1093/inthealth/ihae002.

    PMID: 38547349
  94. 94

    Wolbachia and Lymphatic Filarial Nematodes and Their Implications in the Pathogenesis of the Disease.

    Setegn A, Amare GA, Mihret Y

    Journal of parasitology research 2024; (2024()):3476951 doi:10.1155/2024/3476951.

    PMID: 38725798
  95. 95

    Unraveling Lymphatic Filariasis in an Old Man: A Case Report.

    Handa A, Gaidhane A, Choudhari S

    Cureus 2024; (16(4)):e58167 doi:10.7759/cureus.58167.

    PMID: 38741824
  96. 96

    An Unusual Encounter: Microfilaria Incidentally Detected in the Bone Marrow Aspirate of a Chronic Kidney Disease Patient.

    Lakra PS, Sinha JK, Khurana U, et al.

    Cureus 2024; (16(5)):e59808 doi:10.7759/cureus.59808.

    PMID: 38846222
  97. 97

    Identification and characterisation of Mansonella perstans in the Volta Region of Ghana.

    Opoku M, de Souza DK

    PloS one 2024; (19(6)):e0295089 doi:10.1371/journal.pone.0295089.

    PMID: 38848396
  98. 98

    A review of epidemiology of lymphatic filariasis in Nigeria.

    Waje T, Iliyasu C, Yaki LM, Auta IK

    The Pan African medical journal 2024; (47()):142 doi:10.11604/pamj.2024.47.142.39746.

    PMID: 38933431
  99. 99

    Evaluation of a novel biplex rapid diagnostic test for antibody responses to Loa loa and Onchocerca volvulus infections.

    Campillo JT, Biamonte MA, Hemilembolo MC, et al.

    PLoS neglected tropical diseases 2024; (18(10)):e0012567 doi:10.1371/journal.pntd.0012567.

    PMID: 39388495
  100. 100

    Three decades of research in lymphatic filariasis-lessons learned.

    Krishnasastry S

    Tropical parasitology 2024; (14(2)):65-70 doi:10.4103/tp.tp_22_24.

    PMID: 39411677
  101. 101

    An Overview on Antifilarial Efficacy of Heterocyclic Motifs Encompassing Synthetic Strategies, SAR and Commercialized Medications.

    Tahlan S, Singh S, Pandey KC

    Current topics in medicinal chemistry 2025; (25(11)):1303-1350 doi:10.2174/0115680266321838241024073444.

    PMID: 39492774
  102. 102

    A picture speaks a thousand words: A case of ocular Loa loa.

    Abdalla A, Jaafar SD, Abdalla H, et al.

    IDCases 2024; (38()):e02088 doi:10.1016/j.idcr.2024.e02088.

    PMID: 39494037
  103. 103

    Imported loiasis: Diagnostic and therapeutic challenges.

    Elouardi C, Lefort A, Deconinck L, et al.

    Infectious diseases now 2025; (55(3)):105053 doi:10.1016/j.idnow.2025.105053.

    PMID: 40064469
  104. 104

    Unraveling the Dynamics of Human Filarial Infections: Immunological Responses, Host Manifestations, and Pathogen Biology.

    Rajamanickam A, Babu S

    Pathogens (Basel, Switzerland) 2025; (14(3)) doi:10.3390/pathogens14030223.

    PMID: 40137708
  105. 105

    Antifilarial treatment strategies: a systematic review and network meta-analysis.

    Albadrani MS, Molla A, Elbadawy HM, et al.

    BMC infectious diseases 2025; (25(1)):712 doi:10.1186/s12879-025-11105-z.

    PMID: 40380307
  106. 106

    Access and Awareness of Morbidity Management and Disability Prevention for Lower Limb Lymphatic Filariasis in Post-Mass Drug Administration Districts in Southern India.

    Jog A, Deborah AA, Ramesh RM, et al.

    The American journal of tropical medicine and hygiene 2025; (113(4)):839-843 doi:10.4269/ajtmh.25-0180.

    PMID: 40763726
  107. 107

    Mansonella perstans - the forgotten filaria.

    Ritter M, Hsu HY, Lenz B, et al.

    Trends in parasitology 2025; (41(10)):909-921 doi:10.1016/j.pt.2025.08.003.

    PMID: 40908246
  108. 108

    Piloting lymphoedema management for lymphatic filariasis: experiences and perceptions of patients and stakeholders from Kwale county, coastal Kenya.

    Kepha S, Were V, Okello G, et al.

    BMC public health 2025; (25(1)):3415 doi:10.1186/s12889-025-24303-w.

    PMID: 41068673
  109. 109

    Home self-management experience of gynaecological tumour patients with lower limb lymphoedema: a qualitative study.

    Liu G, Liu Y, Hu J, et al.

    Primary health care research & development 2025; (26()):e81 doi:10.1017/S1463423625100406.

    PMID: 41077997
  110. 110

    Activity of antifilarial drugs on microfilaremia in the treatment of loiasis: a systematic review.

    Michelitsch P, Matthies L, Nordmann T, et al.

    Parasites & vectors 2025; (19(1)):30 doi:10.1186/s13071-025-07189-w.

    PMID: 41372923
  111. 111

    The Death to Onchocerciasis and Lymphatic Filariasis (DOLF) project: Accomplishments and ongoing research.

    Fischer PU, King CL, Budge PJ, et al.

    PLoS neglected tropical diseases 2026; (20(2)):e0013953 doi:10.1371/journal.pntd.0013953.

    PMID: 41632749
  112. 112

    From neglect to empowerment: impact of vocational rehabilitation on quality of life among disabled filarial lymphoedema patients in a brugian-endemic region of South India-a mixed methods evaluation.

    Aravindakshan L, Panicker KN, Mohandas NV, Francis PT

    Transactions of the Royal Society of Tropical Medicine and Hygiene 2026; doi:10.1093/trstmh/trag015.

    PMID: 41783910